Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2011 1
2012 2
2013 1
2015 2
2016 4
2017 4
2018 1
2019 5
2020 4
2021 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration.
Liu D, Webber HC, Bian F, Xu Y, Prakash M, Feng X, Yang M, Yang H, You IJ, Li L, Liu L, Liu P, Huang H, Chang CY, Liu L, Shah SH, Torre A, Welsbie DS, Sun Y, Duan X, Goldberg JL, Braun M, Lansky Z, Hu Y. Liu D, et al. Among authors: webber hc. bioRxiv [Preprint]. 2024 Apr 3:2024.04.02.587832. doi: 10.1101/2024.04.02.587832. bioRxiv. 2024. PMID: 38617277 Free PMC article. Preprint.
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.
Huynh T, Murray J, Flemming CL, Kamili A, Hofmann U, Cheung L, Roundhill EA, Yu DMT, Webber HT, Schwab M, Henderson MJ, Haber M, Norris MD, Fletcher JI. Huynh T, et al. Among authors: webber ht. Biochem Pharmacol. 2020 Feb;172:113770. doi: 10.1016/j.bcp.2019.113770. Epub 2019 Dec 17. Biochem Pharmacol. 2020. PMID: 31862449
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.
Poon E, Liang T, Jamin Y, Walz S, Kwok C, Hakkert A, Barker K, Urban Z, Thway K, Zeid R, Hallsworth A, Box G, Ebus ME, Licciardello MP, Sbirkov Y, Lazaro G, Calton E, Costa BM, Valenti M, De Haven Brandon A, Webber H, Tardif N, Almeida GS, Christova R, Boysen G, Richards MW, Barone G, Ford A, Bayliss R, Clarke PA, De Bono J, Gray NS, Blagg J, Robinson SP, Eccles SA, Zheleva D, Bradner JE, Molenaar J, Vivanco I, Eilers M, Workman P, Lin CY, Chesler L. Poon E, et al. Among authors: webber h. J Clin Invest. 2020 Nov 2;130(11):5875-5892. doi: 10.1172/JCI134132. J Clin Invest. 2020. PMID: 33016930 Free PMC article.
The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork.
Sugali CK, Rayana NP, Dai J, Peng M, Harris SL, Webber HC, Liu S, Dixon SG, Parekh PH, Martin EA, Cantor LB, Fellman RL, Godfrey DG, Butler MR, Emanuel ME, Grover DS, Smith OU, Clark AF, Raghunathan VK, Mao W. Sugali CK, et al. Among authors: webber hc. Am J Pathol. 2021 Jun;191(6):1020-1035. doi: 10.1016/j.ajpath.2021.02.018. Epub 2021 Mar 8. Am J Pathol. 2021. PMID: 33705750 Free PMC article.
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
Evageliou NF, Haber M, Vu A, Laetsch TW, Murray J, Gamble LD, Cheng NC, Liu K, Reese M, Corrigan KA, Ziegler DS, Webber H, Hayes CS, Pawel B, Marshall GM, Zhao H, Gilmour SK, Norris MD, Hogarty MD. Evageliou NF, et al. Among authors: webber h. Clin Cancer Res. 2016 Sep 1;22(17):4391-404. doi: 10.1158/1078-0432.CCR-15-2539. Epub 2016 Mar 24. Clin Cancer Res. 2016. PMID: 27012811
26 results